JENBURKT PHARMACEUTICALS
Back to Income Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹152 Cr | ₹142 Cr | ₹137 Cr | ₹124 Cr | ₹109 Cr |
What is the latest Revenue of JENBURKT PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹152 Cr |
| Mar2024 | ₹142 Cr |
| Mar2023 | ₹137 Cr |
| Mar2022 | ₹124 Cr |
| Mar2021 | ₹109 Cr |
How is Revenue of JENBURKT PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹152 Cr | 6.85 | |
| Mar2024 | ₹142 Cr | 3.82 | |
| Mar2023 | ₹137 Cr | 10.30 | |
| Mar2022 | ₹124 Cr | 13.44 | |
| Mar2021 | ₹109 Cr | - | |
Compare Revenue of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹444.4 Cr | -0.1% | 1.2% | -0.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -0.1% |
1.2% |
-0.2% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses